Ticket sales have ended
Thank you for registering. You are opting in to receive emails from Puma Biotechnology. At any time, you will have the option to unsubscribe. Puma Biotechnology NERLYNX® (neratinib) for early stage HER2+ breast cancer
PRG & Puma Biotechnology Patient Education Webinar
Online event
Thursday, June 2, 2022 • 7 PM - 8 PM EDT